Teva Pharmaceutical Industries (Allegra Distribution Rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Teva Pharmaceutical Industries (Allegra Distribution Rights) General Information

Description

Portfolio of drug-distribution rights under the Allegra brand. The portfolio is comprised of exclusive U.S. store brand rights to sell and distribute OTC versions of Fexofenadine HCl 180 mg and 60 mg tabs, plus Fexofenadine HCl 60 mg and Pseudoephedrine 120 mg tabs, the generic versions of Sanofi -Aventis' Allegra and Allegra D-12 products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Other Services (B2C Non-Financial)
Acquirer
Primary Office
  • 5 Basel Street
  • PO Box 3190 Petach
  • Tikva
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Teva Pharmaceutical Industries (Allegra Distribution Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Teva Pharmaceutical Industries (Allegra Distribution Rights)‘s full profile, request access.

Request a free trial

Teva Pharmaceutical Industries (Allegra Distribution Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Teva Pharmaceutical Industries (Allegra Distribution Rights)‘s full profile, request access.

Request a free trial